“The sale of our Saf-T-Pak business enables Cantel Medical to better focus on our core markets and strategic opportunities. Specialty packaging no longer fits our strategic growth objectives,” said Andrew Krakauer, CEO of Cantel Medical.
The net proceeds from the sale, after taxes, are expected to be $7 million.
More articles on gastroenterology:
FDA approves Ethicon’s sealant patch for bleeding control during adult liver surgery
Squaring off in GI: Employment vs. private practice
Dr. Christopher Meyer named CEO of Holzer Health System
